These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4129458)

  • 1. [Stability of drug sensitivity of the M. tuberculosis after its passage in guinea pigs (study conducted at the central tuberculosis laboratory at Kenis)].
    Zvkov MP; Roulet E; Gava N
    Probl Tuberk; 1973; 51(3):74-9. PubMed ID: 4129458
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug resistance and speed of growth of M. tuberculosis. I. Growth on drug-free medium.
    Zykov MP; Donets JI
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):35-9. PubMed ID: 4113511
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics of African Mycobacterium tuberculosis. Constancy of drug susceptibility in laboratory animals.
    Zykov MP; Roulet H; Gaya N
    Am Rev Respir Dis; 1973 Jul; 108(1):93-100. PubMed ID: 4123739
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug resistance of Mycobacterium tuberculosis in Chandigarh.
    Mahajan RC; Agarwal SC
    Indian J Med Res; 1968 Aug; 56(8):1180-7. PubMed ID: 4179833
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance and speed of growth of M. tuberculosis. 2. Vulnerable and invulnerable types of resistance.
    Zykov MP; Donets JI; Poti SJ
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):40-56. PubMed ID: 4113512
    [No Abstract]   [Full Text] [Related]  

  • 6. Virulence of multidrugresistant Mycobacterium tuberculosis.
    Zykov MP; Roulet H; Gaya N; Poti SJ
    Exp Pathol (Jena); 1973; 8(2):73-97. PubMed ID: 4204722
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of Mycobacterium tuberculosis in Africa. Vulnerable and invulnerable types of drug resistance.
    Zykov MP; Donets JI; Poti SJ
    Am Rev Respir Dis; 1972 May; 105(5):715-35. PubMed ID: 4112019
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thiacetazone (Tb-1): recent experimental and clinical data].
    Grosset J; Benhassine M
    Bibl Tuberc; 1970; 26():107-53. PubMed ID: 4189928
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of drug resistance of M. tuberculosis strains using three different culture media.
    Montalbine V; Collins FM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):260-2. PubMed ID: 4101361
    [No Abstract]   [Full Text] [Related]  

  • 10. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tuberculosis by microcultivation on slides in blood medium].
    Smirnov VD
    Antibiotiki; 1971; 16(8):738-40. PubMed ID: 5003152
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of African M. tuberculosis.
    Zykov MP; Patel RI
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):70-83. PubMed ID: 4097678
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug sensitivity patterns of Mycobacterium tuberculosis isolated in Addis Ababa.
    Lemma E; Valdivia Alvarez JA; Gebre-Tsadik G; Echemendia Font M
    Ethiop Med J; 1984 Apr; 22(2):93-6. PubMed ID: 6202516
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug resistance of Mycobacterium tuberculosis].
    Malaguzzi Valeri F; Rossi F
    G Pneumol; 1970 Apr; 14(2):121-5. PubMed ID: 5005066
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacteria resistant to streptomycin, P.A.S. and isoniazid.
    Brown LR; Courteau RD; Davies JC; Stoughton RR; Weitz A
    Cent Afr J Med; 1973 Jun; 19(6):116-9. PubMed ID: 4125461
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlation of lipid fractions, toxicity and virulence of M. tuberculosis isolated from patients treated with antibacterial preparations].
    Nemsadze MN
    Probl Tuberk; 1971; 49(11):66-9. PubMed ID: 5004859
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 20. The method of vertical diffusion for the determination of drug sensitivity of Mycobacterium tuberculosis and the concentration of biologically active tubazid in the blood serum of patients with tuberculosis.
    Gelberg SI; Kulgovenya PS
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):447-56. PubMed ID: 4629404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.